Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company’s equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
| 2022-01-18 5:30 pm Purchase | 13D | FUSION PHARMACEUTICALS INC FUSN | TPG GP A LLC | 2,621,436 6.1% | 2,621,436 (New Position) | View |
| 2021-02-10 4:02 pm Purchase | 13G | FUSION PHARMACEUTICALS INC FUSN | ADAMS STREET PARTNERS LLC | 3,492,749 8.4% | 3,492,749 (New Position) | View |
| 2021-02-09 4:10 pm Purchase | 13G | FUSION PHARMACEUTICALS INC FUSN | VARIAN MEDICAL SYSTEMS INC VAR | 3,256,972 7.81% | 3,256,972 (New Position) | View |
| 2021-02-08 10:23 am Purchase | 13G | FUSION PHARMACEUTICALS INC FUSN | FMR LLC | 3,129,434 7.499% | 3,129,434 (New Position) | View |
| 2021-02-03 6:37 pm Purchase | 13G | FUSION PHARMACEUTICALS INC FUSN | CANADA PENSION PLAN INVESTMENT BOARD | 3,116,966 7.5% | 3,116,966 (New Position) | View |
| 2020-07-23 1:32 pm Purchase | 13G | FUSION PHARMACEUTICALS INC FUSN | Seroba Life Sciences Management Ltd | 2,021,646 4.85% | 2,021,646 (New Position) | View |
| 2020-07-10 5:00 pm Purchase | 13D | FUSION PHARMACEUTICALS INC FUSN | HealthCap VII L.P. | 3,807,247 9.1% | 3,807,247 (New Position) | View |
| 2020-07-10 4:37 pm Purchase | 13D | FUSION PHARMACEUTICALS INC FUSN | TPG Group Holdings (SBS) Advisors Inc. | 2,621,436 6.3% | 2,621,436 (New Position) | View |
| 2020-07-06 5:57 pm Purchase | 13D | FUSION PHARMACEUTICALS INC FUSN | ORBIMED ADVISORS LLC | 2,997,981 7.2% | 2,997,981 (New Position) | View |
| 2020-07-02 6:21 pm Purchase | 13G | FUSION PHARMACEUTICALS INC FUSN | JOHNSON & JOHNSON JNJ | 3,759,634 9% | 3,759,634 (New Position) | View |